Loading...
Market
Will Summit Therapeutics' market cap reach $25 billion by mid-2024?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Publicly available financial data from stock market websites or financial news outlets
Story
Summit Therapeutics Raises $235M in Private Placement, Market Cap at $18.7B
Sep 12, 2024, 12:44 PM
Summit Therapeutics has raised $235 million through a private placement, issuing 10.35 million shares at $22.70 per share. Of the total amount, $79 million was raised by insiders, with the remaining $156 million coming from multiple leading biopharma institutional investors. The company's market capitalization is approximately $18.7 billion. This fundraising effort follows the company's strong pricing and substantial insider participation, reflecting confidence in its future prospects. The raise was also influenced by significant lung cancer data.
View original story
Similar markets
Yes • 50%
No • 50%
Less than $500 million • 25%
$500 million to $1 billion • 25%
$1 billion to $1.5 billion • 25%
More than $1.5 billion • 25%
Yes • 50%
No • 50%
Less than $100 million • 25%
$100 million to $500 million • 25%
$500 million to $1 billion • 25%
Over $1 billion • 25%
Less than $1 billion • 25%
$1 billion to $5 billion • 25%
$5 billion to $10 billion • 25%
More than $10 billion • 25%
Below $3 billion • 25%
$3 billion to $5 billion • 25%
$5 billion to $7 billion • 25%
Above $7 billion • 25%
